title: What is publication? The case of eltrombopag.
authors.affiliation: The Lancet, London NW1 7BY, UK.
authors.forename: Laura
authors.initials: L
authors.lastname: Benham
authors.forename: Lin
authors.initials: L
authors.lastname: Guo
authors.forename: Richard
authors.initials: R
authors.lastname: Turner
mesh_terms: D001565:Benzoates / Q000627:therapeutic use*; D035081:Editorial Policies; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D011643:Publishing / Q000592:standards*; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy* / Q000601:surgery; D011720:Pyrazoles / Q000627:therapeutic use*; D011961:Receptors, Fc / Q000627:therapeutic use; D053628:Receptors, Thrombopoietin / Q000819:agonists*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D013156:Splenectomy; D013926:Thrombopoietin / Q000627:therapeutic use
chemical_list: D001565:Benzoates; D006834:Hydrazines; D011720:Pyrazoles; D011961:Receptors, Fc; D053628:Receptors, Thrombopoietin; D011993:Recombinant Fusion Proteins; D013926:Thrombopoietin; C488777:romiplostim; C520809:eltrombopag